Dr Greco Mark Malijan
Colleges
Greco Mark Malijan
MD, MSc
DPhil Student
Greco joined the Renal Studies Group at the Clinical Trial Service Unit & Epidemiological Studies Unit (CTSU) in 2023.
Using urine biomarker analysis in the EMPA-KIDNEY and UK HARP III trials, his work seeks to better understand the determinants of chronic kidney progression. His project is supported by the departmental studentship, and he is supervised by Professor Will Herrington, Professor Natalie Staplin, Dr Parminder Judge, and Dr Rebecca Sardell.
Prior to his doctoral studies, Greco studied medicine and trained in internal medicine at the University of the Philippines – Philippine General Hospital. He was awarded MSc in International Health and Tropical Medicine from the University of Oxford, with the support of a Philippine government scholarship. He then worked in infectious disease epidemiological research in the San Lazaro Hospital – Nagasaki University Collaborative Research Office.
Greco is deeply passionate about science communication and global health equity. Outside of research and medicine, he enjoys diving into new culinary adventures.
Recent publications
Effects of Empagliflozin on Kidney and Cardiac Magnetic Resonance Imaging Measures in Patients With CKD: An EMPA-KIDNEY Mechanistic Substudy.
Journal article
Zhu D. et al, (2026), Am J Kidney Dis, 87, 564 - 568
Effects of Empagliflozin on Urine Biomarkers in EMPA-KIDNEY.
Journal article
Malijan GB. et al, (2026), Am J Kidney Dis, 87, 553 - 563.e1
Lessons from developing the Papua New Guinea National Health Research Agenda 2025–2030
Journal article
Dindi M. et al, (2026), The Lancet Regional Health - Western Pacific, 68, 101830 - 101830
P-212. The Effects of Magnesium Sulfate on Mortality and Morbidity of Adult Patients with Tetanus in San Lazaro Hospital, Manila, Philippines from January 2012 to December 2021: A Retrospective Cohort Study
Journal article
Malijan GMB. and Sayo ARL., (2026), Open Forum Infectious Diseases, 13
Glucose Interference in Urine Biomarkers and Implications for Sodium-Glucose Cotransporter 2 Inhibition.
Journal article
Malijan GB. et al, (2025), Kidney Int Rep, 10, 4090 - 4093
